Literature DB >> 634472

The effect of position of patient on the passage of metrizamide (Amipaque), meglumine locarmate (Dimer X) and ioserinate (Myelografin) into the blood after lumbar myelography.

U Speck, R Schmidt, V Volkhardt, H Vogelsang.   

Abstract

Lumbar myelography was carried out with the contrast media Amipaque, Dimer X and Myelografin in 10 patients each. Five of the patients treated with each contrast medium were kept in a sitting position after the examination, the others lay flat. Blood levels and excretion were measured up to 24 h. The results are interpreted as follows: 1. After lumbar injection of the contrast media there is a short phase of distribution in the subarachnoid space (lag time) and they then are transferred into the blood with a half-life of 3.9 +/- 2.4 h. The transport from the CSF is almost completed approximately after 24 h. The velocity of transport varies greatly between the individual patients. Watersoluble contrast media presumably flow passively with the CSF through the arachnoid villi into the venous blood. 2. The horizontal position of the patient reduces the lag time until the beginning of the actual transfer of the contrast medium. 3. The transfer of Dimer X begins somewhat later compared with Amipaque and Myelografin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 634472     DOI: 10.1007/bf00418624

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  [Pharmacokinetics and biotransformation of newer contrast media for uro- and angiography in the patient].

Authors:  U Speck; R Nagel; W Leistenschneider; W Mützel
Journal:  Rofo       Date:  1977-09

2.  [Distribution, excretion and absorption of renal I-131-labelled roentgen contrast medium].

Authors:  W SCHLUNGBAUM
Journal:  Fortschr Geb Rontgenstr Nuklearmed       Date:  1962-06

3.  Computed tomography of spinal cord after lumbar intrathecal introduction of metrizamide (computer-assisted myelography).

Authors:  G Di Chiro; D Schellinger
Journal:  Radiology       Date:  1976-07       Impact factor: 11.105

4.  Postural protection against complications in radiculography with dimer X.

Authors:  J P Cécile; G Regnier; A Guaquière; L Doffiny; A Cuvelier
Journal:  Neuroradiology       Date:  1974       Impact factor: 2.804

5.  Perfusion studies of the cerebrospinal fluid absorptive pathways in the dog.

Authors:  D G Potts; V Deonarine; W Welton
Journal:  Radiology       Date:  1972-08       Impact factor: 11.105

6.  Intravenous injections of metrizamide into human volunteers.

Authors:  P Amundsen; O P Foss; H C Godal; S Nitter-Hauge
Journal:  Acta Radiol Suppl       Date:  1973

7.  [Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models (author's transl)].

Authors:  G Heinzel; R Hammer; M Wolf; F W Koss; G Bozler
Journal:  Arzneimittelforschung       Date:  1977

8.  Suprasellar masses on computerised tomography with intrathecal metrizamide.

Authors:  B P Drayer; A E Rosenbaum
Journal:  Lancet       Date:  1976-10-02       Impact factor: 79.321

9.  Absorption of metrizamide from cereb rospinal fluid to blood: pharmacokinetics in humans.

Authors:  K Golman
Journal:  J Pharm Sci       Date:  1975-03       Impact factor: 3.534

10.  [Experience with e new water soluble contrast medium for lumbar myelography (author's transl)].

Authors:  H Vogelsang; U Speck; P Becker; L Blumenbach; O Busse
Journal:  Rontgenblatter       Date:  1976-04
View more
  11 in total

1.  Multiple subcortical haemorrhages following lumbar metrizamide myelography.

Authors:  H C Overbeek; A Keyser
Journal:  J Neurol       Date:  1987-04       Impact factor: 4.849

2.  Subclinical organic psychosyndromes on intrathecal injection of metrizamide for lumbar myelography.

Authors:  S Richert; K Sartor; B Holl
Journal:  Neuroradiology       Date:  1979-10-31       Impact factor: 2.804

3.  Lumbar myelography with iopamidol: a methodological approach to the investigation of side effects.

Authors:  L Provinciali; M Signorino; A R Giovagnoli; M Baroni; F Angeleri; U Salvolini; U Pasquini; M Porta; A Judice; R Cerutti
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

4.  Electroencephalography (EEG) after introduction of water soluble contrast media into cerebrospinal fluid (CSF).

Authors:  H E Nau
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

Review 5.  An overview of the clinical pharmacokinetics of x-ray contrast media.

Authors:  M Bourin; P Jolliet; F Ballereau
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

6.  Absorption of a non-ionic contrast agent from cerebrospinal fluid to blood.

Authors:  K Golman; I Wiik; S Salvesen
Journal:  Neuroradiology       Date:  1979-12-12       Impact factor: 2.804

7.  Iotrol, a new water-soluble non-ionic dimeric contrast medium for intrathecal use.

Authors:  B Hammer; E Deisenhammer
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

8.  Absorption of iohexol from cerebrospinal fluid to blood: pharmacokinetics in humans.

Authors:  B Olsson; O P Eldevik; T A Grønnerød
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

9.  Quincke oedema following intrathecal administration of metrizamide.

Authors:  C J Bendel; P H Hoogland
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

10.  Mental disorders after myelography with metrizamide and other water-soluble contrast media.

Authors:  R C Schmidt
Journal:  Neuroradiology       Date:  1980-04       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.